All News

What has been your experience with returning to work during and after cancer treatment? What would make the transition easier? Do you have advice to share with patients and survivors?

I'm writing my own chapter within a bigger story.

CURE spoke with Axel Grothey about advances in the treatment of colorectal cancer.

Adcetris met its primary endpoint in a phase 3 trial for patients with T-cell lymphoma.

A recent phase 3 study showed that Sutent extended disease-free survival for patients with renal cell carcinoma.

Knowing the possible risks for breast cancer is important, and some of them are within our control.

No follow-up scan is easy, but some feel routine. When they don't, we have no choice as survivors but to face our fears and move forward, one step at a time, one scan at a time.

Gregory Zagaja discusses the benefits of surgery for prostate cancer, as well as recent updates in the field.

Claire Friedman, Memorial Sloan Kettering Cancer Center, discusses some of the factors that doctors and elderly patients with melanoma should discuss before deciding on a treatment plan with immunotherapy. Immunotherapy is not one-size-fits all, and patients should be informed of the pros and cons of each option.

The FDA granted ribociclib a breakthrough therapy designation for some patients with breast cancer.

Breast cancer and melanoma survivor shares time management tips to fellow survivors.

There must be a connection between chemo and AFIB.

Maintenance Revlimid was shown to improve overall survival in patients with multiple myeloma.

Pracinostat was granted a breakthrough therapy designation by the FDA for use in some patients with AML.

The addition of Onivyde to some chemotherapy regimens for pancreatic cancer improved survival and did not affect patients' quality of life.

Even with the many advances in cancer research, there are still limits to what medicine can achieve.

Handling two illnesses at once is not always easy.

Stanley Liauw discusses the current and future role of radiation therapy for patients with prostate cancer.

AI therapy can put breast cancer survivors at risk for bone fractures, making bone density monitoring important.

What happens when you meet an oncologist in training?

After cancer, calm and anxiety go from two separate states of mind to form a new way of thinking and perhaps even fighting the fears that come with being a cancer survivor.

Researchers are hoping to harness the leukemia-killing antibodies made by cured AML patients to treat others with the disease.

In treating low-risk breast cancer, adding novel agents isn't always necessary, Hope S. Rugo says.

One often hears cancer survivors proclaim with pride, honor and dignity, “I never asked why this happened to me.” Unintentionally, this sets the standard for those who follow, creating the unwritten rule that asking why is to admit weakness, to be unfit for battle.

Time is limited and the time for experiences with loved ones is today, writes breast cancer survivor Barbara Tako.

Every day seems to link another food or behavior to my cancer diagnosis. Those endless recommendations sometimes just minimize what I am going through. Am I wrong to say enough is enough?

The NCCN recently designated Optune, which has been shown to slow and reverse tumor growth, a category 2A recommendation for some patients with GBM.

CURE spoke with the founder of CORAL 65 on the unique issues older patients with cancer face.